These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31790280)

  • 21. Seizure characteristics and the use of anti-epileptic drugs in children and young people with brain tumours and epileptic seizures: Analysis of regional paediatric cancer service population.
    Pilotto C; Liu JF; Walker DA; Whitehouse WP
    Seizure; 2018 May; 58():17-21. PubMed ID: 29609145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of music on seizure frequency in institutionalized subjects with severe/profound intellectual disability and drug-resistant epilepsy.
    D'Alessandro P; Giuglietti M; Baglioni A; Verdolini N; Murgia N; Piccirilli M; Elisei S
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):399-404. PubMed ID: 28953798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizures and Antiepileptic Drugs: From Pathophysiology to Clinical Practice.
    Carcak N; Ozkara C
    Curr Pharm Des; 2017; 23(42):6376-6388. PubMed ID: 29141532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy.
    Monaghan R; O'Dwyer M; Luus R; Mulryan N; McCallion P; McCarron M; Henman MC
    J Appl Res Intellect Disabil; 2021 May; 34(3):818-829. PubMed ID: 33530136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN; Nguyen HP; Sullivan SD
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy, intellectual disability, and living environment: a critical review.
    van Blarikom W; Tan IY; Aldenkamp AP; van Gennep AT
    Epilepsy Behav; 2006 Aug; 9(1):14-8. PubMed ID: 16714148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors of drug-resistant epilepsy in children.
    Karaoğlu P; Yaş U; Polat Aİ; Ayanoğlu M; Hız S
    Turk J Med Sci; 2021 Jun; 51(3):1249-1252. PubMed ID: 33600098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of neuropsychiatric comorbidities in patients with both epilepsy and intellectual disability.
    van Ool JS; Snoeijen-Schouwenaars FM; Schelhaas HJ; Tan IY; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2016 Jul; 60():130-137. PubMed ID: 27206231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for the treatment of epilepsies in general practice in Belgium.
    Boon P; Engelborghs S; Hauman H; Jansen A; Lagae L; Legros B; Ossemann M; Sadzot B; Urbain E; van Rijckevorsel K
    Acta Neurol Belg; 2008 Dec; 108(4):118-30. PubMed ID: 19239040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutics in pediatric epilepsy, Part 1: The new antiepileptic drugs and the ketogenic diet.
    Jarrar RG; Buchhalter JR
    Mayo Clin Proc; 2003 Mar; 78(3):359-70. PubMed ID: 12630590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seizure and Sudden Unexpected Death in Epilepsy (SUDEP) characteristics in an urban UK intellectual disability service.
    Sun JJ; Perera B; Henley W; Ashby S; Shankar R
    Seizure; 2020 Aug; 80():18-23. PubMed ID: 32485614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority.
    Kinney MO; Chester V; Tromans S; Alexander RT; Angus-Leppan H; Bagary M; Cock H; Devapriam J; Hassiotis A; Mula M; Reuber M; Ring H; Roy A; Scheepers M; Shankar R
    Seizure; 2020 Oct; 81():111-116. PubMed ID: 32777744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drugs as prophylaxis for post-craniotomy seizures.
    Pulman J; Greenhalgh J; Marson AG
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007286. PubMed ID: 23450575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seizures and therapy in adolescents with uncomplicated epilepsy.
    Räty LK; Wilde-Larsson B; Söderfeldt BA
    Seizure; 2003 Jun; 12(4):229-36. PubMed ID: 12763471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin as add-on treatment for epilepsy.
    Brigo F; Del Felice A
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006967. PubMed ID: 22696363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
    Töllner K; Twele F; Löscher W
    Epilepsy Behav; 2016 Apr; 57(Pt A):95-104. PubMed ID: 26930359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and adverse effects of established and new antiepileptic drugs.
    Mattson RH
    Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complex epilepsy patient: intricacies of assessment and treatment.
    Kanner AM
    Epilepsia; 2003; 44 Suppl 5():3-8. PubMed ID: 12859356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mood, anxiety, and perceived quality of life in adults with epilepsy and intellectual disability.
    Snoeijen-Schouwenaars FM; van Ool JS; Tan IY; Aldenkamp AP; Schelhaas HJ; Hendriksen JGM
    Acta Neurol Scand; 2019 Jun; 139(6):519-525. PubMed ID: 30820944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.